** Shares of Trajan Group Holdings TRJ.AX rise 11.5% to A$0.925, eyeing their best trading session since mid-May 2024
** Stock hits highest since February 6
** Life sciences co logs 1H25 adjusted EBITDA of A$7.9 mln ($4.97 mln) vs A$4 mln during the same period last year
** Attributes earnings growth to strong distribution from its capital equipment segment
** Also reaffirms net revenue guidance of A$160 mln-A$165 mln for fiscal 2025 vs A$155 mln in FY24
** More than 66,000 shares change hands, 3.6 times the 30-day avg
** Traja down 18.1% YTD, including current session's moves
($1 = 1.5908 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.